JP2005530732A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005530732A5 JP2005530732A5 JP2003584094A JP2003584094A JP2005530732A5 JP 2005530732 A5 JP2005530732 A5 JP 2005530732A5 JP 2003584094 A JP2003584094 A JP 2003584094A JP 2003584094 A JP2003584094 A JP 2003584094A JP 2005530732 A5 JP2005530732 A5 JP 2005530732A5
- Authority
- JP
- Japan
- Prior art keywords
- glp
- pharmaceutical composition
- composition according
- compound
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37165002P | 2002-04-10 | 2002-04-10 | |
| PCT/US2003/008457 WO2003087139A2 (en) | 2002-04-10 | 2003-03-27 | Treatment of gastroparesis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005530732A JP2005530732A (ja) | 2005-10-13 |
| JP2005530732A5 true JP2005530732A5 (enExample) | 2006-05-18 |
Family
ID=29250714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003584094A Pending JP2005530732A (ja) | 2002-04-10 | 2003-03-27 | 胃不全麻痺の治療 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20050164925A1 (enExample) |
| EP (1) | EP1496924A4 (enExample) |
| JP (1) | JP2005530732A (enExample) |
| KR (1) | KR20040098063A (enExample) |
| CN (1) | CN1735423A (enExample) |
| AU (1) | AU2003220403A1 (enExample) |
| BR (1) | BR0308904A (enExample) |
| CA (1) | CA2480858A1 (enExample) |
| EA (1) | EA200401345A1 (enExample) |
| EC (1) | ECSP045345A (enExample) |
| HR (1) | HRP20040939A2 (enExample) |
| IL (1) | IL164266A0 (enExample) |
| MX (1) | MXPA04009929A (enExample) |
| NO (1) | NO20044815L (enExample) |
| NZ (1) | NZ535684A (enExample) |
| PL (1) | PL373658A1 (enExample) |
| WO (1) | WO2003087139A2 (enExample) |
| ZA (1) | ZA200408111B (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8666495B2 (en) | 1999-03-05 | 2014-03-04 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
| US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
| JP4960700B2 (ja) | 2003-07-21 | 2012-06-27 | メタキュアー リミティド | 疾患を治療し、血糖を制御する際に使用するための胃腸処置方法および装置 |
| EP1670515A2 (en) * | 2003-09-19 | 2006-06-21 | Novo Nordisk A/S | Albumin-binding derivatives of therapeutic peptides |
| TW200522976A (en) * | 2003-09-19 | 2005-07-16 | Novo Nordisk As | Novel plasma protein affinity tags |
| EP1793891B1 (en) | 2004-08-18 | 2011-11-09 | Metacure Limited | Monitoring, analysis, and regulation of eating habits |
| EP1868679B1 (en) | 2005-02-17 | 2017-05-03 | MetaCure Limited | Non-immediate effects of therapy |
| EP1880298B1 (en) | 2005-02-17 | 2016-07-13 | Metacure Limited | Charger with data transfer capabilities |
| TWI362392B (en) | 2005-03-18 | 2012-04-21 | Novo Nordisk As | Acylated glp-1 compounds |
| ES2484796T3 (es) | 2005-03-18 | 2014-08-12 | Novo Nordisk A/S | Compuestos de GLP-1 extendidos |
| US8463404B2 (en) | 2005-03-24 | 2013-06-11 | Metacure Limited | Electrode assemblies, tools, and methods for gastric wall implantation |
| ATE533403T1 (de) * | 2005-03-24 | 2011-12-15 | Metacure Ltd | Drahtlose leitungen für magen-darm-trakt- anwendungen |
| US8301256B2 (en) | 2005-06-02 | 2012-10-30 | Metacure Limited | GI lead implantation |
| US8442841B2 (en) * | 2005-10-20 | 2013-05-14 | Matacure N.V. | Patient selection method for assisting weight loss |
| US8295932B2 (en) | 2005-12-05 | 2012-10-23 | Metacure Limited | Ingestible capsule for appetite regulation |
| EP2007804B1 (en) * | 2006-04-20 | 2014-06-18 | Amgen, Inc | Glp-1 compounds |
| AU2012203915B9 (en) * | 2006-04-20 | 2014-10-09 | Amgen Inc. | GLP-1 compounds |
| WO2008139463A2 (en) * | 2007-05-09 | 2008-11-20 | Metacure Ltd. | Analysis and regulation of food intake |
| US8423130B2 (en) * | 2008-05-09 | 2013-04-16 | Metacure Limited | Optimization of thresholds for eating detection |
| WO2010015668A1 (en) | 2008-08-06 | 2010-02-11 | Novo Nordisk A/S | Conjugated proteins with prolonged in vivo efficacy |
| JP5816097B2 (ja) | 2009-01-22 | 2015-11-18 | ノヴォ・ノルディスク・ヘルス・ケア・アーゲー | 安定な成長ホルモン化合物 |
| WO2011015649A1 (en) | 2009-08-06 | 2011-02-10 | Novo Nordisk Health Care Ag | Growth hormones with prolonged in-vivo efficacy |
| EP2482840A4 (en) * | 2009-08-07 | 2013-06-26 | Mannkind Corp | VAL (8) GLP-1 COMPOSITION AND METHOD FOR THE TREATMENT OF REAGENTS AND / OR IRRITATION SYNDROME |
| PL2525834T3 (pl) | 2010-01-22 | 2020-10-19 | Novo Nordisk Health Care Ag | Hormony wzrostu o przedłużonej skuteczności in-vivo |
| RU2012134974A (ru) | 2010-01-22 | 2014-02-27 | Ново Нордиск Хелс Кеа Аг | Стабилизированное соединение гормона роста |
| US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
| PH12012502018A1 (en) | 2010-04-30 | 2018-03-21 | Sanwa Kagaku Kenkyusho Co | Peptide for improving biostability of bioactive substance, and bioactive substance having improved biostability |
| UA116217C2 (uk) | 2012-10-09 | 2018-02-26 | Санофі | Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону |
| HUE035803T2 (en) | 2012-12-21 | 2018-05-28 | Sanofi Sa | Dual GLP1 / GIP or trigonal GLP1 / GIP / glucagon agonists |
| ES2841123T3 (es) | 2013-04-05 | 2021-07-07 | Formulacion Del Compuesto De La Hormona De Crecimiento | Formulación del compuesto de la hormona de crecimiento |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6268343B1 (en) * | 1996-08-30 | 2001-07-31 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| US5981488A (en) * | 1997-03-31 | 1999-11-09 | Eli Lillly And Company | Glucagon-like peptide-1 analogs |
| IL142707A0 (en) * | 2000-04-27 | 2002-03-10 | Pfizer Prod Inc | Methods of treating obesity using a neurotensin receptor ligand |
-
2003
- 2003-03-27 BR BR0308904-5A patent/BR0308904A/pt not_active IP Right Cessation
- 2003-03-27 CA CA002480858A patent/CA2480858A1/en not_active Abandoned
- 2003-03-27 HR HRP20040939 patent/HRP20040939A2/hr not_active Application Discontinuation
- 2003-03-27 EP EP03716707A patent/EP1496924A4/en not_active Withdrawn
- 2003-03-27 KR KR10-2004-7016025A patent/KR20040098063A/ko not_active Ceased
- 2003-03-27 IL IL16426603A patent/IL164266A0/xx unknown
- 2003-03-27 WO PCT/US2003/008457 patent/WO2003087139A2/en not_active Ceased
- 2003-03-27 MX MXPA04009929A patent/MXPA04009929A/es not_active Application Discontinuation
- 2003-03-27 EA EA200401345A patent/EA200401345A1/ru unknown
- 2003-03-27 AU AU2003220403A patent/AU2003220403A1/en not_active Abandoned
- 2003-03-27 NZ NZ535684A patent/NZ535684A/xx unknown
- 2003-03-27 JP JP2003584094A patent/JP2005530732A/ja active Pending
- 2003-03-27 PL PL03373658A patent/PL373658A1/xx unknown
- 2003-03-27 US US10/508,762 patent/US20050164925A1/en not_active Abandoned
- 2003-03-27 CN CNA038080079A patent/CN1735423A/zh active Pending
-
2004
- 2004-10-07 ZA ZA200408111A patent/ZA200408111B/xx unknown
- 2004-10-08 EC EC2004005345A patent/ECSP045345A/es unknown
- 2004-11-05 NO NO20044815A patent/NO20044815L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240376175A1 (en) | Novel GLP-1 Analogues | |
| KR102906485B1 (ko) | 변형된 gip 펩티드 유사체 | |
| JP2007001987A5 (enExample) | ||
| ES2444622T3 (es) | Derivado peptídico insulinotrópico en el que se ha modificado su aminoácido N-terminal | |
| CN102711804B (zh) | 包含glp-1激动剂和甲硫氨酸的药物组合物 | |
| RU2485135C2 (ru) | Соединения оксинтомодулина (варианты), фармацевтическая композиция на их основе, способы лечения и профилактики ожирения и сопутствующих заболеваний (варианты) и лекарственное средство (варианты) | |
| ES2113879T3 (es) | Analogos de glp-1 utiles para el tratamiento de diabetes. | |
| JP2006514104A5 (enExample) | ||
| JP2002526454A5 (enExample) | ||
| JP2007523881A5 (enExample) | ||
| CN108271356A (zh) | 肠降血糖素-胰岛素缀合物 | |
| RU2007134156A (ru) | Ацилированные glp-1 соединения | |
| TWI353250B (en) | Glp-1 pharmaceutical compositions | |
| JP2011526886A5 (enExample) | ||
| US20180280480A1 (en) | Compositions and peptides having dual glp-1r and glp-2r agonist activity | |
| JP2018500291A (ja) | 制御放出および持続的放出のためのｅｌｐ融合タンパク質 | |
| JP2022543826A5 (enExample) | ||
| AU2022222674A1 (en) | Glucagon-like peptide-1 receptor antagonists | |
| US20240058422A1 (en) | Glucagon-like peptide-1 receptor antagonists | |
| WO2015180634A1 (zh) | 用于治疗2型糖尿病的长效肠激素多肽类似物及应用 | |
| HK40117578A (en) | Glucagon-like peptide-1 receptor antagonists | |
| RU2008129731A (ru) | Новые пептиды-т-хелперные антигенные детерминанты (thd) | |
| HK1207088B (en) | Insulinotropic peptide derivative wherein its n-terminal amino acid is modified |